關於 Cytori Therapeutics, Inc.
Cerenome, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Cerenome also commercialized a molecular diagnostic service, CNSide®.
Source: Wikipedia
總部3020 Callan Road, 92121, San Diego, US
成立時間2016
狀態營運中
專利205 項專利
IMPROVEMENT OF ENDOTHELIAL CELL FUNCTIONWO2019168685A1 · 2019
REGENERATIVE CELL THERAPY FOR MUSCULOSKELETAL DISORDERSEP3522984A1 · 2019
法律資訊
| 法定名稱 | Cytori Therapeutics, Inc. |
|---|---|
| LEI | 549300XD2PHUC73HMY31在 GLEIF 上查看 ↗ |
| 登記地址 | 3020 Callan Road, 92121, San Diego, US |
| 狀態 | 營運中 |
來源: GLEIF · 更新於 2026年10月16日